Memantine 20mg tablets

País: Reino Unido

Língua: inglês

Origem: MHRA (Medicines & Healthcare Products Regulatory Agency)

Compre agora

Ingredientes ativos:

Memantine hydrochloride

Disponível em:

Lupin Healthcare (UK

Código ATC:

N06DX01

DCI (Denominação Comum Internacional):

Memantine hydrochloride

Dosagem:

20mg

Forma farmacêutica:

Tablet

Via de administração:

Oral

Classe:

No Controlled Drug Status

Tipo de prescrição:

Valid as a prescribable product

Resumo do produto:

BNF: ; GTIN: 8901107024833

Folheto informativo - Bula

                                PACKAGE LEAFLET: INFORMATION FOR THE USER
MEMANTINE HYDROCHLORIDE LUPIN 5MG + 10MG + 15MG + 20MG FILM-COATED
TABLETS,
TITRATION PACK
Memantine hydrochloride
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT
CONTAINS IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may
harm them, even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any
possible side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Memantine tablets are and what they are used for
2.
What you need to know before you take Memantine tablets
3.
How to take Memantine tablets
4.
Possible side effects
5.
How to store Memantine tablets
6.
Contents of the pack and other information
1.
WHAT MEMANTINE TABLETS ARE AND WHAT THEY ARE USED FOR
Memantine tablets belongs to a group of medicines known as
anti-dementia medicines.
Memory loss in Alzheimer’s disease is due to a disturbance of
message signals in the brain.
The brain contains so-called N-methyl-D-aspartate (NMDA)-receptors
that are involved in
transmitting nerve signals important in learning and memory. Memantine
tablets belongs to a
group of medicines called NMDA receptor antagonists. Memantine tablets
acts on these
NMDA-receptors improving the transmission of nerve signals and the
memory.
•
Memantine tablets are used for the treatment of patients with moderate
to severe
alzheimer’s disease.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE MEMANTINE TABLETS.
DO NOT TAKE MEMANTINE TABLETS:
-
if you are allergic to memantine hydrochloride or any of the other
ingredients
of this medicine (listed in section 6).
If you are not sure, talk to your doctor or pharmacist before taking
Memantine tablets.
WARNINGS AND PRECAUTIONS
Talk to your doctor or pharmacist before taking Memantine tab
                                
                                Leia o documento completo
                                
                            

Características técnicas

                                OBJECT 1
MEMANTINE HYDROCHLORIDE LUPIN 5MG, 10 MG, 15
MG & 20 MG FILM-COATED TABLETS, TITRATION PACK
Summary of Product Characteristics Updated 08-Oct-2015 | Lupin
Healthcare (UK) Ltd
1. Name of the medicinal product
Memantine hydrochloride Lupin 5mg film-coated tablets
Memantine hydrochloride Lupin 10mg film-coated tablets
Memantine hydrochloride Lupin 15mg film-coated tablets
Memantine hydrochloride Lupin 20mg film-coated tablets
2. Qualitative and quantitative composition
Each film-coated tablet contains 5mg of memantine hydrochloride
equivalent to 4.15mg memantine.
Each film-coated tablet contains 10mg of memantine hydrochloride
equivalent to 8.31mg memantine.
Each film-coated tablet contains 15mg of memantine hydrochloride
equivalent to 12.46mg memantine.
Each film-coated tablet contains 20mg of memantine hydrochloride
equivalent to 16.62mg memantine.
For a full list of excipients, see section 6.1.
3. Pharmaceutical form
Film-coated tablets.
Memantine 5mg tablets are white to off white coloured, approximately
10 x 4 mm, capsule shaped,
biconvex, film-coated tablets, debossed with “5“ on one side and
plain on the other side.
Memantine 10mg tablets are white to off white coloured, approximately
11 x 6 mm, oval shaped, film-
coated tablets, debossed with “10“ on one side and “breakline“ on
the other side.
Memantine 15mg tablets are mustard yellow coloured, approximately 14 x
7 mm, oval shaped, film-
coated tablets, debossed with “15“ on one side and plain on the
other side.
Memantine 20mg tablets are brownish pink coloured, approximately 14 x
7 mm, oval shaped, film-coated
tablets, debossed with “20“ on one side and “breakline“ on the
other side
Memantine 10mg and 20mg tablets can be divided into equal doses.
4. Clinical particulars
4.1 Therapeutic indications
Treatment of patients with moderate to severe Alzheimer's disease.
4.2 Posology and method of administration
Treatment should be initiated and supervised by a physician
experienced in the diagnosis and treatment of
Alzheimer's dementia. Therap
                                
                                Leia o documento completo
                                
                            

Pesquisar alertas relacionados a este produto